Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

NCT05203276 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lung Neoplasms

Interventions

DRUG: Envafolimab
DRUG: Endostar

Sponsor

The First People's Hospital of Lianyungang